The usefulness of MIBI scanning to detect underlying carcinoma in women with acute mastitis

Breast Journal

Volumn 6, Issue 2, 2000, Pages 126-129

  Pappo, Itzhak ^a,b   Horne, Tifha ^a   Weissberg, Dorit ^a   Wasserman, Ilan ^a   Orda, Ruben ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Mastitis; Scintimammography; Sestamibi

Indexed keywords

ANTIBIOTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CLINICAL ARTICLE; FEMALE; HUMAN; MASTITIS; SCINTIMAMMOGRAPHY;

EID: 0033994767     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2000.98107.x     Document Type: Article

References (20)

1. Harris JR, Morrow M, Bondadonna G. Cancer of the breast. In: De Vita VT, Hellman S, Rosenberg S, eds. Cancer: principles and practice of oncology. New York: JB Lippincott, 1993:1264-332.
2. Kelsy JL, Gammon MD. The epidemiology of breast cancer. Cancer 1991;41:146-65.
3. Shapiro S, Venet W, Strax P. Ten to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
4. Tabar L, Fagerberg GJG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomized trial from the Breast Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
5. Balon HR, Fink-Bennet DM, Stoffer SS. Technetium-99m uptake by recurrent Hurtle cell carcinoma of the thyroid. J Nucl Med 1992;33:1393-95.
6. Caner B, Kitapcl M, Unlu M, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med 1992;33:319-24.
7. Maublant J, DeLatur M, Mestas D, et al. Technetium-m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 1996;37:922-25.
8. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992;33:1801-7.
9. Aktolum C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-21. Clin Nucl Med 1992;17:171-76.
10. Pappo I, Home T, Orda R. Tc-99m-sestamibi scintimammography for the diagnosis of breast malignancies. Breast J 1998;4:441-46.
11. 99m-MIBI) breast scintography for early detection of breast cancer. In: Bergmann, Kroiss A, Sinzinger H, eds. Radioactive isotopes in clinical medicine and research XXII. Basel, Switzerland: Birkhäuser Verlag, 1997:43-49.
12. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-89.
13. Loprinzi CL, Okuno SH, Pisansky TM, et al. Postsurgil changes of the breast that mimic inflammatory breast carcinoma. Mayo Clin Proc 1996;71:552-55.
14. O'Tuama LA, Packard AB, Treves SD, et al. SPECT imaging of pediatric brain tumors with hexakis (methoxy-isobutylisonitril) technetium I. J Nucl Med 1990;31:2040-41.
15. Villanueva-Meyer J, Leonard MH Jr, Briscoe E, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996;37:926-30.
16. Chambler AF, Drew PJ, Hill AD, Darzi A, Monson JR. Inflammatory breast carcinoma. Surg Oncol 1995;4:245-54.
17. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-97.
18. 99mTc sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press, 1994:181-234.
19. Palmedo H, Scomburg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-30.
20. Stowasser G, Pernegger C, Brinninger G, et al. Evaluation of Tc-99m sestamibi (MIBI) in patients with suspected breast cancer in comparison with Tl-201 [abstract]. J Nucl Med 1994;35:231.